Cargando…

Effects of Wisconsin’s handgun waiting period repeal on suicide rates

OBJECTIVE: To estimate the effect of a handgun purchase waiting period repeal on handgun and firearm suicides in Wisconsin. METHODS: Data for outcome and predictor variables were obtained for the 1999–2020 study period. Synthetic controls were used to assess the impact of Wisconsin’s waiting period...

Descripción completa

Detalles Bibliográficos
Autor principal:	Oliphant, Stephen N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Student Submission
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726970/ https://www.ncbi.nlm.nih.gov/pubmed/36423914 http://dx.doi.org/10.1136/ip-2022-044719

Ejemplares similares

Handgun waiting periods reduce gun deaths
por: Luca, Michael, et al.
Publicado: (2017)

An intersectional analysis of historical and contemporary structural racism on non-fatal shootings in Baltimore, Maryland
por: Uzzi, Mudia, et al.
Publicado: (2023)

Handgun Divestment and Risk of Suicide
por: Swanson, Sonja A., et al.
Publicado: (2022)

Patterns of handgun divestment among handgun owners in California
por: Swanson, Sonja A., et al.
Publicado: (2022)

Suicide prevention in pharmaceutical education: Raising awareness with inspiring stories
por: Vincent, Philippe D., et al.
Publicado: (2016)

Machine Learning Analysis of Handgun Transactions to Predict Firearm Suicide Risk
por: Laqueur, Hannah S., et al.
Publicado: (2022)

Criminal charge history, handgun purchasing, and demographic characteristics of legal handgun purchasers in California
por: Pear, Veronica A., et al.
Publicado: (2021)

State handgun purchase age minimums in the US and adolescent suicide rates: regression discontinuity and difference-in-differences analyses
por: Raifman, Julia, et al.
Publicado: (2020)

Rates of Vascular Events in Patients With Migraine: A MarketScan(®) Database Retrospective Cohort Study
por: Gill, Karminder, et al.
Publicado: (2020)

Handgun purchasing characteristics and firearm suicide risk: a nested case–control study
por: Schleimer, Julia P., et al.
Publicado: (2021)

Impact on length of stay and readmission rates when converting oral to long-acting injectable antipsychotics in schizophrenia or schizoaffective disorder
por: Chou, Fabienne, et al.
Publicado: (2016)

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine
por: Ford, Janet H., et al.
Publicado: (2020)

Characterization of transit rates in the large intestine of mice following treatment with a CGRP antibody, CGRP receptor antibody, and small molecule CGRP receptor antagonists
por: Johnson, Kirk W., et al.
Publicado: (2022)

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
por: Rothrock, John F., et al.
Publicado: (2019)

100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double‐Blind, Placebo‐Controlled EVOLVE‐1 and EVOLVE‐2 Studies
por: Rosen, Noah, et al.
Publicado: (2018)

Commentary: The pulmonary autograft, too valuable to repeal
por: Al Halees, Zohair
Publicado: (2021)

Parliament’s Constitution: Legislative Disruption of Implied Repeal
por: Hameed, Asif
Publicado: (2023)

Evaluation of the 6‐item Identify Chronic Migraine screener in a large medical group
por: Pavlovic, Jelena M., et al.
Publicado: (2021)

Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses
por: Fiedler‐Kelly, Jill, et al.
Publicado: (2020)

IMPROVING THE EFFECTIVENESS AND EFFICIENCY OF EVIDENCE PRODUCTION FOR HEALTH TECHNOLOGY ASSESSMENT
por: Facey, Karen, et al.
Publicado: (2015)

Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
por: Detke, Holland C., et al.
Publicado: (2019)

STOP 301: A Phase 3, open‐label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD(®)) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients
por: Smith, Timothy R., et al.
Publicado: (2021)

Assessment of Rural-Urban and Geospatial Differences in Perceived Handgun Access and Reported Suicidality Among Youth in Colorado
por: Spark, Talia L., et al.
Publicado: (2021)

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study
por: Lipton, Richard B., et al.
Publicado: (2021)

Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial
por: Yarnitsky, David, et al.
Publicado: (2019)

Effectiveness of Oxygen and Other Acute Treatments for Cluster Headache: Results From the Cluster Headache Questionnaire, an International Survey
por: Pearson, Stuart M., et al.
Publicado: (2019)

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials
por: Stauffer, Virginia L., et al.
Publicado: (2019)

Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Buse, Dawn C., et al.
Publicado: (2019)

No “Wearing‐Off Effect” Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long‐Term Study
por: Blumenfeld, Andrew M., et al.
Publicado: (2020)

AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks
por: Tepper, Stewart J, et al.
Publicado: (2015)

The effect of needle size on cerebrospinal fluid collection time and post‐dural puncture headache: A retrospective cohort study
por: van Dongen, Robin M., et al.
Publicado: (2021)

The impact of the repeal of the federal individual insurance mandate on uninsurance
por: Soni, Aparna
Publicado: (2022)

The Effect of Psychiatric Comorbidities on Headache‐Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Lipton, Richard B., et al.
Publicado: (2020)

A pilot study evaluating the effectiveness of a medicines education group in a mental health inpatient setting: A UK perspective
por: White, Daniel, et al.
Publicado: (2018)

A Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
por: Depre, Christophe, et al.
Publicado: (2018)

Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double‐Blind, Sham‐Controlled ACT1 Study
por: Silberstein, Stephen D., et al.
Publicado: (2016)

Understanding the migraine treatment landscape prior to the introduction of calcitonin gene‐related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
por: Kawata, Ariane K., et al.
Publicado: (2021)

Evaluation of the use of low-dose quetiapine and the risk of metabolic consequences: A retrospective review
por: Carr, Chelsea N., et al.
Publicado: (2016)

The effectiveness of Foley catheter balloon tamponade versus expanding sponges and hemostatic granules for catastrophic penetrating groin hemorrhage with small skin defect: A comparative study in a live tissue porcine model with evaluation of a concise training program
por: Vrancken, Suzanne M., et al.
Publicado: (2023)

The impact of spikes in handgun acquisitions on firearm-related harms
por: Laqueur, Hannah S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6hnrf6fbu87ejkvkddfe46oea6